These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37442189)

  • 21. System analysis of
    Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Systematic Analysis of Dysregulated Long Non-Coding RNAs/microRNAs/mRNAs in Lung Squamous Cell Carcinoma.
    Zhang TJ; Cao JS; Li Q; An GS; Ni JH; Jia HT; Li SY
    Am J Med Sci; 2020 Dec; 360(6):701-710. PubMed ID: 33012486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer.
    Wu J; Luo D; Li S
    Breast Cancer (Dove Med Press); 2020; 12():267-277. PubMed ID: 33324095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of
    Hu Y; Yang L; Lu Y; Wang Y; Jiang J; Liu Y; Cao Q
    Evid Based Complement Alternat Med; 2022; 2022():2116006. PubMed ID: 36193154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Network pharmacology and bioinformatics analysis on the underlying mechanisms of baicalein against oral squamous cell carcinoma.
    Tang B; Dong Y
    J Gene Med; 2023 Jun; 25(6):e3490. PubMed ID: 36843559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of potential diagnostic and therapeutic target genes for lung squamous cell carcinoma.
    Zhang N; Wang H; Xie Q; Cao H; Wu F; Di Wu DB; Wan Y
    Oncol Lett; 2019 Jul; 18(1):169-180. PubMed ID: 31289486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LINC01936 inhibits the proliferation and metastasis of lung squamous cell carcinoma probably by EMT signaling and immune infiltration.
    Tian Q; Liu X; Li A; Wu H; Xie Y; Zhang H; Wu F; Chen Y; Bai C; Zhang X
    PeerJ; 2023; 11():e16447. PubMed ID: 38084139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of network pharmacology and molecular docking-based strategy to determine potential pharmacological mechanism of Liuwei Dihuang pill against tinnitus.
    Wu Z; Zhu Z; Cao J; Wu W; Hu S; Deng C; Xie Q; Huang X; You C
    Medicine (Baltimore); 2022 Nov; 101(46):e31711. PubMed ID: 36401375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Taxus chinensis against non-small cell lung cancer.
    Zhang S; Wang J; Zhang H
    Medicine (Baltimore); 2023 Nov; 102(44):e35826. PubMed ID: 37933017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Desmoglein 3 and Keratin 14 for Distinguishing Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Dong Y; Li S; Sun X; Wang Y; Lu T; Wo Y; Leng X; Kong D; Jiao W
    Onco Targets Ther; 2020; 13():11111-11124. PubMed ID: 33149622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Cepharanthine on the Stemness of Lung Squamous Cell Carcinoma Based on Network Pharmacology and Bioinformatics.
    Liu B; Deng JX
    Biomed Res Int; 2022; 2022():5956526. PubMed ID: 36483630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of tumor-suppressor genes in lung squamous cell carcinoma through integrated bioinformatics analyses.
    Li H; Lei Y; Li G; Huang Y
    Oncol Res; 2023; 32(1):187-197. PubMed ID: 38188687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening and identification of key biomarkers in lung squamous cell carcinoma by bioinformatics analysis.
    Man J; Zhang X; Dong H; Li S; Yu X; Meng L; Gu X; Yan H; Cui J; Lai Y
    Oncol Lett; 2019 Nov; 18(5):5185-5196. PubMed ID: 31612029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and validation of key genes associated with non-small-cell lung cancer.
    Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
    J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a cancer-associated fibroblast classifier for predicting prognosis and therapeutic response in lung squamous cell carcinoma.
    Lai X; Fu G; Du H; Xie Z; Lin S; Li Q; Lin K
    Medicine (Baltimore); 2023 Sep; 102(38):e35005. PubMed ID: 37746966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.
    Yu H; Pang Z; Li G; Gu T
    J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A network pharmacology and bioinformatics exploration of the possible molecular mechanisms of Fuzheng Xiaoliu Granule for the treatment of hepatocellular carcinoma.
    Fan T; Chen X; Yang F; Li Y; Gao Q; Li S; Chen X; Chen X
    J Clin Transl Res; 2023 Jun; 9(3):182-194. PubMed ID: 37275579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Network Pharmacology-based Strategy to Investigate Pharmacological Mechanisms of Qingbutongluo Pill for Treatment of Brucellosis.
    Wang J; He JW; Liu JS; Li JE; Cui QY; Wang YR; Zhou WG
    Comb Chem High Throughput Screen; 2023; 26(4):706-718. PubMed ID: 35692141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of Glycitein in the Treatment of Colon Cancer Based on Network Pharmacology and Molecular Docking.
    Xiang T; Jin W
    Lifestyle Genom; 2023; 16(1):1-10. PubMed ID: 36183698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.